Merck (MRK) Divestments (2009 - 2021)

Merck (MRK) reported Divestments of -$82.0 million for Q2 2021, down 57.69% quarter-over-quarter from -$52.0 million in Q1 2021.

Merck (MRK) Divestments (2009 - 2021) Analysis & Trends

Merck (MRK) has 7 years of Divestments data on file, last reported at -$82.0 million in Q2 2021.

Divestments for Q2 2021 came in at -$82.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was -$82.0 million (up 59.41% YoY), and the FY2021 annual result was -$134.0 million, up 46.4% from the prior year.
Divestments eased to -$82.0 million in Q2 2021 per MRK's latest filing, from -$52.0 million in the prior quarter.
Over five years, Divestments peaked at -$52.0 million in Q1 2021 and troughed at -$82.0 million in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn	330.30 Mn
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn	-
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn	-
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn	-
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn	-
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn	-
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn	-
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn	-
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn	312.00 Mn
10	Novartis Ag	108.28 Bn	107.60 Bn	-	-2.00 Mn

Download Data